Literature DB >> 920131

Madelung's deformity. A follow-up study of 26 cases and a review of the literature.

J B Nielsen.   

Abstract

Madelung's deformity, the history, aetiology, pathogenesis and prognosis, is discussed, on the basis of the literature. The author's material of 26 cases has been followed up. Thirteen of them were treated by resection of the ulna head or shortening of the ulna, with or without wedge osteotomy of the radius. The result was an improvement in pain and a cosmetic improvement, but mobility was unaltered. Spontaneous improvement in the symptoms is common, so that a waiting policy, and observation of the patient until growth ceases, is recommended.

Entities:  

Mesh:

Year:  1977        PMID: 920131     DOI: 10.3109/17453677708992012

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  5 in total

1.  Surgical correction of Madelung's deformity by combined corrective radioulnar osteotomy: 14 cases with four-year minimum follow-up.

Authors:  Jean-Michel Laffosse; Abdelaziz Abid; Frank Accadbled; Gorka Knör; Jérôme Sales de Gauzy; Jean-Philippe Cahuzac
Journal:  Int Orthop       Date:  2008-12-20       Impact factor: 3.075

2.  Hereditary disorders with maladies of the wrist and elbow.

Authors:  J K Sekiya; P J Jebson; D S Louis
Journal:  Iowa Orthop J       Date:  1997

Review 3.  Madelung deformity and Madelung-type deformities: a review of the clinical and radiological characteristics.

Authors:  Sayed Ali; Summer Kaplan; Theresa Kaufman; Sarah Fenerty; Scott Kozin; Dan A Zlotolow
Journal:  Pediatr Radiol       Date:  2015-07-02

4.  [Madelung's deformity - Why choose the Sauvé-Kapandji osteotomy?]

Authors:  A G Graftiaux; P Kehr
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-10

5.  High resolution 3.0 Tesla MR imaging findings in patients with bilateral Madelung's deformity.

Authors:  Christoph Stehling; Martin Langer; Isabelle Nassenstein; Rainald Bachmann; Walter Heindel; Volker Vieth
Journal:  Surg Radiol Anat       Date:  2009-02-19       Impact factor: 1.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.